Mankind Pharma Limited (BOM:543904)

Market Cap	960.38B
Revenue (ttm)	116.41B
Net Income (ttm)	20.41B
Shares Out	n/a
EPS (ttm)	50.81
PE Ratio	47.04
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,819
Average Volume	11,920
Open	2,348.50
Previous Close	2,346.75
Day's Range	2,312.65 - 2,348.50
52-Week Range	1,910.10 - 3,050.00
Beta	n/a
RSI	37.27
Earnings Date	Feb 4, 2025

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and m...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 19,540
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543904

Financial Performance

In 2023, Mankind Pharma's revenue was 103.35 billion, an increase of 18.12% compared to the previous year's 87.49 billion. Earnings were 19.13 billion, an increase of 49.23%.